Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2025 | 05-2024 | 05-2023 | 05-2022 | 05-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,717 | 12,013 | -99,563 | -116,715 | -32,294 |
| Depreciation Amortization | 8,027 | 7,954 | 14,477 | 96,207 | 19,867 |
| Income taxes - deferred | N/A | N/A | 357 | -6,825 | -7,874 |
| Accounts receivable | -2,262 | -3,263 | 10,824 | -6,138 | 5,775 |
| Accounts payable and accrued liabilities | -1,670 | -6,676 | 16,038 | 9,343 | -5,982 |
| Other Working Capital | -4,695 | -3,699 | 19,791 | -3,101 | 9,763 |
| Other Operating Activity | 39,111 | -6,072 | 20,635 | 4,636 | 27,216 |
| Operating Cash Flow | $-206 | $257 | $-17,441 | $-22,593 | $16,471 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,415 | -18,395 | -21,482 | -28,799 | -12,310 |
| Net Acquisitions | N/A | N/A | 16,671 | 73,500 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 45,100 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -9,839 | 0 |
| Investing Cash Flow | $-6,415 | $-18,395 | $-4,811 | $79,962 | $-12,310 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 128,567 | 149,586 | 31,450 | 55,111 | 100,000 |
| Debt Issued | 2,400 | 5,000 | 150,000 | 20,000 | 170,000 |
| Debt Repayment | -930 | -714 | -123,690 | -86,411 | -114,130 |
| Common Stock Issued | 23,850 | 724 | 4,822 | N/A | N/A |
| Common Stock Repurchased | -1,270 | -152 | N/A | N/A | N/A |
| Other Financing Activity | -146,193 | -146,935 | -22,882 | -45,721 | -159,289 |
| Financing Cash Flow | $6,424 | $7,509 | $39,700 | $-57,021 | $-3,419 |
| Beginning Cash Position | 8,462 | 19,091 | 1,643 | 1,295 | 553 |
| End Cash Position | 8,265 | 8,462 | 19,091 | 1,643 | 1,295 |
| Net Cash Flow | $-197 | $-10,629 | $17,448 | $348 | $742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206 | 257 | -17,441 | -22,593 | 16,471 |
| Capital Expenditure | -13,415 | -18,395 | -21,482 | -29,940 | -25,223 |
| Free Cash Flow | -13,621 | -18,138 | -38,923 | -52,533 | -8,752 |